XETRA •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/28/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeXETRA
Market Capitalization29.93 mln
Float123 mln
Earnings Date08/31/2025
Piotroski F-Score
2
/ 9
Weak
Relative Strength
100
/ 100
Top performer
Debt / Equity
-0.86
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
Business Description
BioNxt Solutions Inc. is a Canadian pharmaceutical company founded in 2017 and headquartered in Vancouver, focused on developing and selling advanced drug delivery products across Austria, Germany, and Switzerland. The company's pipeline targets a range of serious medical conditions, including multiple sclerosis, lupus, rheumatoid arthritis, and myasthenia gravis, alongside longevity and weight management treatments. BioNxt also develops diagnostic screening tools and works to refine how active pharmaceutical ingredients are delivered through the skin or as dissolvable oral films, with a particular interest in neurological applications.
